Drug Information

Drug General Information
Drug ID
D09LQF
Former ID
DNC009894
Drug Name
N-(3,5-dimethoxyphenyl)-4-methyl-2-nitrobenzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530118]
Formula
C16H16N2O5
Canonical SMILES
CC1=CC(=C(C=C1)C(=O)NC2=CC(=CC(=C2)OC)OC)[N+](=O)[O-]
InChI
1S/C16H16N2O5/c1-10-4-5-14(15(6-10)18(20)21)16(19)17-11-7-12(22-2)9-13(8-11)23-3/h4-9H,1-3H3,(H,17,19)
InChIKey
GFSKVJZKSAGFJY-UHFFFAOYSA-N
PubChem Compound ID
45272830
Target and Pathway
Target(s) Enoyl-[acyl-carrier-protein] reductase [NADH] Target Info Inhibitor [530118]
References
Ref 530118Eur J Med Chem. 2009 Sep;44(9):3718-30. Epub 2009 Apr 8.Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
Ref 530118Eur J Med Chem. 2009 Sep;44(9):3718-30. Epub 2009 Apr 8.Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.